Europe

Israel advances medical marijuana export law in ‘huge leap for industry’

An Israeli government committee approved the first draft law on the export of medical cannabis, an important step toward the government’s long-delayed plan to foster an MMJ export industry. The draft law was vetted by the Internal Affairs Committee, headed by Yoav Kish, and now moves to the Knesset – Israel’s Legislature – where lawmakers will […]

Read More

Lawsuit throws German cannabis program into limbo; deadline delayed to Dec. 11

Another lawsuit challenging the application process to grow medical cannabis in Germany could throw the already-delayed domestic cultivation plans even further into a state of uncertainty.

In an update to the public tender, the German Federal Institute for Drugs and Medical Devices (BfArM) disclosed a lawsuit filed in the Dusseldorf Higher Regional Court (OLG Dusseldorf).

Read More

Aurora ‘expects sufficient supply’ of marijuana to meet adult-use demand

Aurora Cannabis expects to have sufficient supply next year to meet demand in Canada’s shortage-ridden recreational marijuana market, according to a regulatory filing the Alberta company released Monday alongside its quarterly results. Aurora – one of Canada’s largest licensed producers of companies – reported revenue of 29 million Canadian dollars ($21 million) for the quarter […]

Read More

Aphria seeks EU GMP certification before closing deal for German distributor

Aphria, one of Canada’s largest medical cannabis companies, aims to obtain an essential European quality standard certification before closing its deal to buy a large distributor of pharmaceutical products in Germany. Aphria announced last week its intention to buy Densborn, Germany-based CC Pharma for 24.5 million euros ($28 million) in cash on closing and another […]

Read More

Poland approves Aurora Cannabis as medical marijuana supplier

Alberta-based Aurora Cannabis said it received the green light to ship medical cannabis to Poland, making the Canadian company “the first nongovernment-run business” to win approval to supply medical marijuana products in the eastern European country. Aurora Deutschland GmbH – Aurora’s German subsidiary – will ship the products to a pain treatment center and a hospital […]

Read More

Former PM Mulroney: ‘Others will follow’ Canada’s lead on cannabis

Former Prime Minister Brian Mulroney says other countries will follow Canada’s lead on cannabis legalization, but it will take time. On the same day Canada legalized marijuana for recreational use, Mulroney announced his intention to join the board of Acreage Holdings – one of the largest marijuana companies in the United States. Mulroney – prime […]

Read More

Lithuania becomes Europe’s latest adopter of medical marijuana

Lithuania’s Parliament voted unanimously to give doctors the ability to prescribe marijuana to treat certain health conditions, making it the latest European Union country to approve the use of medical cannabis. Agence France-Presse reported that the pending law will come into force May 1, and the sale of medical marijuana will require a license from […]

Read More

Is Canada’s marijuana legalization a ‘template’ for the world to follow?

Canada took its first steps into a future of legal cannabis Wednesday, but what that means for prohibition in other countries largely remains to be seen. Will other countries follow Canada’s move toward ending prohibition? What impact will ending prohibition there have on global medical cannabis markets? Canadian Senator Tony Dean believes every country will […]

Read More

United Kingdom sets date for first medical cannabis prescriptions

Specially trained doctors will be able to legally issue prescriptions for cannabis-based medicines for the first time in the United Kingdom starting Nov. 1, marking an important milestone for the medical marijuana industry in the country. The law introduced in the U.K. Parliament today will ultimately pave the way for one of the largest MMJ […]

Read More

CBD drugmaker GW Pharmaceuticals poised to raise $300 million

GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals to treat rare […]

Read More

Medical marijuana demand, imports continue to climb in Germany

While Germany is on track to become one of the largest federally legal medical marijuana markets in the world, a lack of publicly available data on consumption makes it difficult for companies to assess the actual market opportunities. Unlike Health Canada, German authorities don’t publish centralized statistical information of the number of patients or amount […]

Read More